DCALPharmaceuticals
Dishman Carbogen Amcis Ltd — Profit & Loss Statement
₹129.97
-7.38%
Dishman Carbogen Amcis Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBITDA | 472.51 Cr | 308.57 Cr | 300.52 Cr | 342.56 Cr | — |
| Write Off | 18.11 Cr | — | — | — | 5.05 Cr |
| Net Non Operating Interest Income Expense | -159.46 Cr | -119.97 Cr | -63.24 Cr | -29.00 Cr | — |
| Interest Expense Non Operating | 159.46 Cr | 119.97 Cr | 74.39 Cr | 39.22 Cr | — |
| Operating Income | 175.20 Cr | -24.36 Cr | 105.49 Cr | 29.85 Cr | — |
| Operating Expense | 2.03K Cr | 2.04K Cr | 1.68K Cr | 1.65K Cr | — |
| Other Operating Expenses | 447.34 Cr | 523.92 Cr | 310.84 Cr | 245.83 Cr | — |
| Depreciation And Amortization In Income Statement | 293.74 Cr | 310.86 Cr | 280.72 Cr | 307.59 Cr | — |
| Depreciation Income Statement | 293.74 Cr | 310.86 Cr | 217.54 Cr | 207.04 Cr | — |
| Gross Profit | 2.21K Cr | 2.02K Cr | 1.78K Cr | 1.68K Cr | — |
| Cost Of Revenue | 501.65 Cr | 597.19 Cr | 534.21 Cr | 458.88 Cr | — |
| Total Revenue | 2.71K Cr | 2.62K Cr | 2.32K Cr | 2.14K Cr | — |
| Operating Revenue | 2.71K Cr | 2.62K Cr | 2.32K Cr | 2.14K Cr | — |
| Tax Effect Of Unusual Items | -5.43 Cr | -1.84 Cr | -15.42 Cr | -3.54 Cr | — |
| Tax Rate For Calcs | 0.30 | 0.30 | 0.30 | 0.30 | — |
| Normalized EBITDA | 490.62 Cr | 314.71 Cr | 351.92 Cr | 354.36 Cr | — |
| Total Unusual Items | -18.11 Cr | -6.14 Cr | -51.40 Cr | -11.80 Cr | — |
| Total Unusual Items Excluding Goodwill | -18.11 Cr | -6.14 Cr | -51.40 Cr | -11.80 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 3.24 Cr | -153.45 Cr | -29.80 Cr | 18.01 Cr | — |
| Reconciled Depreciation | 293.74 Cr | 310.86 Cr | 280.72 Cr | 307.59 Cr | — |
| Reconciled Cost Of Revenue | 501.65 Cr | 597.19 Cr | 534.21 Cr | 458.88 Cr | — |
| EBIT | 178.77 Cr | -2.29 Cr | 19.80 Cr | 34.97 Cr | — |
| Net Interest Income | -159.46 Cr | -119.97 Cr | -63.24 Cr | -29.00 Cr | — |
| Interest Expense | 159.46 Cr | 119.97 Cr | 74.39 Cr | 39.22 Cr | — |
| Normalized Income | 15.92 Cr | -149.15 Cr | 6.18 Cr | 26.27 Cr | — |
| Net Income From Continuing And Discontinued Operation | 3.24 Cr | -153.45 Cr | -29.80 Cr | 18.01 Cr | — |
| Total Expenses | 2.54K Cr | 2.64K Cr | 2.21K Cr | 2.11K Cr | — |
| Diluted Average Shares | 15.43 Cr | 15.67 Cr | 15.68 Cr | 15.68 Cr | — |
| Basic Average Shares | 15.43 Cr | 15.67 Cr | 15.68 Cr | 15.68 Cr | — |
| Diluted EPS | 0.21 | -9.79 | -1.90 | 1.15 | — |
| Basic EPS | 0.21 | -9.79 | -1.90 | 1.15 | — |
| Diluted NI Availto Com Stockholders | 3.24 Cr | -153.45 Cr | -29.80 Cr | 18.01 Cr | — |
| Net Income Common Stockholders | 3.24 Cr | -153.45 Cr | -29.80 Cr | 18.01 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 3.24 Cr | -153.45 Cr | -29.80 Cr | 18.01 Cr | — |
| Minority Interests | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Including Noncontrolling Interests | 3.24 Cr | -153.45 Cr | -29.80 Cr | 18.01 Cr | — |
| Net Income Continuous Operations | 3.24 Cr | -153.45 Cr | -29.80 Cr | 18.01 Cr | — |
| Tax Provision | 16.07 Cr | 31.19 Cr | -24.79 Cr | -22.26 Cr | — |
| Pretax Income | 19.31 Cr | -122.26 Cr | -54.59 Cr | -4.25 Cr | — |
| Other Non Operating Income Expenses | 21.68 Cr | 28.12 Cr | 9.20 Cr | 19.50 Cr | — |
| Special Income Charges | -18.11 Cr | -6.14 Cr | -51.72 Cr | -16.57 Cr | — |
| Interest Income | — | 13.00 Cr | 18.25 Cr | 19.15 Cr | 21.77 Cr |
| Other Special Charges | — | 11.53 Cr | 51.72 Cr | 16.57 Cr | 22.10 Cr |
| Total Other Finance Cost | — | 5.17 Cr | 7.10 Cr | 8.93 Cr | 4.48 Cr |
| Interest Income Non Operating | — | 13.00 Cr | 18.25 Cr | 19.15 Cr | 21.77 Cr |
| Rent Expense Supplemental | — | 10.01 Cr | 8.76 Cr | 8.49 Cr | 6.54 Cr |
| Amortization | — | 58.75 Cr | 63.18 Cr | 100.55 Cr | 103.38 Cr |
| Selling General And Administration | — | 139.22 Cr | 135.81 Cr | 101.60 Cr | 85.03 Cr |
| Selling And Marketing Expense | — | 24.80 Cr | 35.47 Cr | 29.44 Cr | 21.94 Cr |
| General And Administrative Expense | — | 114.42 Cr | 100.34 Cr | 72.16 Cr | 63.09 Cr |
| Rent And Landing Fees | — | 10.01 Cr | 8.76 Cr | 8.49 Cr | 6.54 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dishman Carbogen Amcis Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.